文献速递心力衰竭与心肌病

儿童扩张型心肌病无心脏移植生存率改善

Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

基于儿科心肌病登记研究,将1953例18岁以下扩张型心肌病患儿按诊断年代分为早期队列(1990-1999年,1199例)和晚期队列(2000-2009年,754例),比较无移植生存率。两队列特发性扩张型心肌病比例(64% vs 63%)、中位年龄(1.6 vs 1.7岁)、左室舒张末z值(+4.2 vs +4.2)和左室缩短分数(16% vs 17%)相似,超声心动图正常化率(30% vs 27%)和心脏移植率(24% vs 24%)相近,但早期队列死亡率更高(18% vs 9%,p=0.04)。早期队列独立预测死亡(HR 1.4,95%CI 1.04-1.9,p=0.03)。

要点

  • 儿童扩张型心肌病近期诊断者生存率改善,死亡风险降低。
  • 生存改善与心脏移植无关,两年代移植率均为24%。
  • 早期诊断年代是死亡的独立预测因素(HR 1.4)。

核心结论

  • 儿童扩张型心肌病在较近年代生存率改善,且与心脏移植使用率无关。

研究设计与样本

  • 基于儿科心肌病登记研究的队列分析,纳入1953例18岁以下扩张型心肌病患儿,按诊断年代分为早期队列(1990-1999年,1199例)和晚期队列(2000-2009年,754例),采用竞争风险和多变量模型分析。

主要发现

  • 早期队列死亡率高于晚期队列(18% vs 9%,p=0.04)。
  • 两队列超声心动图正常化率相似(30% vs 27%),心脏移植率相同(24% vs 24%)。
  • 早期队列独立预测死亡(HR 1.4,95%CI 1.04-1.9,p=0.03)。
  • 两队列特发性扩张型心肌病比例(64% vs 63%)、中位年龄(1.6 vs 1.7岁)、左室舒张末z值(+4.2 vs +4.2)和左室缩短分数(16% vs 17%)相似。

临床怎么用

  • 儿童扩张型心肌病诊断后应关注长期无移植生存,近期年代管理改善可能独立于心脏移植。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies of children with dilated cardiomyopathy (DCM) have suggested that improved survival has been primarily due to utilization of heart transplantation. OBJECTIVES: This study sought to determine transplant-free survival for these children over 20 years and identify the clinical characteristics at diagnosis that predicted death. METHODS: Children <18 years of age with some type of DCM enrolled in the Pediatric Cardiomyopathy Registry were divided by year of diagnosis into an early cohort (1990 to 1999) and a late cohort (2000 to 2009). Competing risks and multivariable modeling were used to estimate the cumulative incidence of death, transplant, and echocardiographic normalization by cohort and to identify the factors associated with death. RESULTS: Of 1,953 children, 1,199 were in the early cohort and 754 were in the late cohort. Most children in both cohorts had idiopathic DCM (64% vs. 63%, respectively). Median age (1.6 vs. 1.7 years), left ventricular end-diastolic z-scores (+4.2 vs. +4.2), and left ventricular fractional shortening (16% vs. 17%) at diagnosis were similar between cohorts. Although the rates of echocardiographic normalization (30% and 27%) and heart transplantation (24% and 24%) were similar, the death rate was higher in the early cohort than in the late cohort (18% vs. 9%; p = 0.04). Being in the early cohort (hazard ratio: 1.4; 95% confidence interval: 1.04 to 1.9; p = 0.03) independently predicted death. CONCLUSIONS: Children with DCM have improved survival in the more recent era. This appears to be associated with factors other than heart transplantation, which was equally prevalent in both eras. (Pediatric Cardiomyopathy Registry [PCMR]; NCT00005391).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Singh RK, Canter CE, Shi L, et al. Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy. J Am Coll Cardiol. 2017. PMID: 29169474. doi:10.1016/j.jacc.2017.09.1089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。